- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05725824
Investigations of Ear Tip Performance, Perceptions, and Experiences (IETPPE)
July 25, 2024 updated by: University of Arizona
Novel Technology Adoption in the Audiology Clinic: Investigations of Ear Tip Performance, Perceptions, and Experiences
Normal hearing participants will be fit with a hearing aid and different types of customized earmolds.
Hearing aids will be programmed to a simulated mild, flat, sensorineural hearing loss of 30 dB HL from 250-8000Hz.
Objective acoustic real ear measures and subjective ratings of sound quality and physical comfort will be evaluated and compared between earmolds.
Findings will help researchers to better understand the impacts of different earmolds and how each might affect overall point-of-care.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arizona
-
Tucson, Arizona, United States, 85721
- University of Arizona
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 89 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Normal hearing thresholds (<25 dB HL) at octave frequencies from 250-8000Hz.
- Normal otoscopy: patent ear canals with normal appearing eardrums and aerated middle ear, bilaterally.
- English as primary spoken language.
Exclusion Criteria:
- history of extensive or current outer or middle ear pathology.
- history of extensive outer or middle ear surgery.
- history of neurological or cognitive disorder.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Third-party control
Ear canal impressions will be will be packaged and sent to a professional third-party manufacturer for fabrication in an acrylic material-type.
These will serve as the control earmolds, by which the in-house study/intervention earmolds will be compared against.
To control for style of earmolds, all earmolds will be made in a skeleton style with a sound bore that accommodates size #13 tubing and a separate select-a-vent (SAV).
|
Hearing aids will be fit with three different types of customized earmolds.
They will only wear each earmold group for the duration of the test (total = ~2.5 hours).
Hearing aids will be programmed to a simulated mild, flat, sensorineural hearing loss of 30 dB HL from 250-8000Hz.
A short washout period will follow completion of testing with ear earmold group.
|
|
Experimental: In-house Study group_Resin
Custom earmold impressions will be scanned and edited using computer-aided design software.
These 3D earmold meshes will then be converted to g-code using licensed software and sent to a stereolithography 3D printer for fabrication.
Participants will only wear these study earmolds for the duration of testing.To control for style of earmolds, all earmolds will be made in a skeleton style with a sound bore that accommodates size #13 tubing and a separate select-a-vent (SAV).
|
Hearing aids will be fit with three different types of customized earmolds.
They will only wear each earmold group for the duration of the test (total = ~2.5 hours).
Hearing aids will be programmed to a simulated mild, flat, sensorineural hearing loss of 30 dB HL from 250-8000Hz.
A short washout period will follow completion of testing with ear earmold group.
|
|
Experimental: In-house Study group_PLA
Custom earmold impressions will be scanned and edited using computer-aided design software.
These 3D earmold meshes will then be converted to g-code using licensed software and sent to a fused deposition modeling 3D printer for fabrication.
Participants will only wear these study earmolds for the duration of testing.
To control for style of earmolds, all earmolds will be made in a skeleton style with a sound bore that accommodates size #13 tubing and a separate select-a-vent (SAV).
|
Hearing aids will be fit with three different types of customized earmolds.
They will only wear each earmold group for the duration of the test (total = ~2.5 hours).
Hearing aids will be programmed to a simulated mild, flat, sensorineural hearing loss of 30 dB HL from 250-8000Hz.
A short washout period will follow completion of testing with ear earmold group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Real Ear Measures
Time Frame: 15 minutes
|
Evaluation of ear canal acoustics with participant wearing a hearing aid and earmold type (3d party control, in-house_Resin, in-house_PLA).
Then, a thin microphone tube is placed in the ear canal to measure the average amount gain (dB SPL) across various frequencies (250-8000Hz) while the participant sits in front of a speaker playing sound samples.
Results are recorded in gain (dB SPL) across frequencies.
Once complete, the earmold type is changed and recording is repeated until all ear mold material types have been tested for each individual.
Arms/Groups were collapsed for RM-ANOVA to compare between various earmold types.
A post-hoc paired t-test w/ Bonferroni correction was utilized to compare ear mold material types.
|
15 minutes
|
|
Outer Effectiveness of Auditory Rehabilitation (EAR) Questionnaire
Time Frame: 2nd listening session appointment (15 minutes)
|
A questionnaire eliciting patient perception of physical comfort, quality of voice, and overall self-perceived satisfaction.
Includes 12 items (5 point) that are scored on a 0 to 100, with 100 representing best possible function/rating
|
2nd listening session appointment (15 minutes)
|
|
Physical Dimensions
Time Frame: Prior to 2nd listening session appointment (15 minutes)
|
Physical dimensions of each ear mold type (3rd party Control, in-house_Resin, in-house_PLA) were taken using digital calipers in millimeters prior to being worn by participants.
|
Prior to 2nd listening session appointment (15 minutes)
|
|
Production Variable
Time Frame: Prior to 2nd listening session appointment (15 minutes)
|
The total raw cost ($) for each ear mold type (3rd party_control, in-house_RES, and in-house_PLA).
|
Prior to 2nd listening session appointment (15 minutes)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical variables
Time Frame: Prior to 2nd listening session appointment (~7-14 days)
|
Physical dimensions of earmolds will be taken using digital calipers.
Does not require participants to be present.
|
Prior to 2nd listening session appointment (~7-14 days)
|
|
Production variables
Time Frame: Prior to 2nd listening session appointment (~7-14 days)
|
The total raw cost ($) and time (min) of production will be measured for each earmold group.
|
Prior to 2nd listening session appointment (~7-14 days)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 30, 2023
Primary Completion (Actual)
January 17, 2024
Study Completion (Actual)
January 17, 2024
Study Registration Dates
First Submitted
February 3, 2023
First Submitted That Met QC Criteria
February 3, 2023
First Posted (Actual)
February 13, 2023
Study Record Updates
Last Update Posted (Actual)
July 29, 2024
Last Update Submitted That Met QC Criteria
July 25, 2024
Last Verified
July 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- STUDY00002336
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.